When you buy through links on our articles, Future and its syndication partners may earn a commission. Amyloid plaques (depicted in orange) are a central feature of Alzheimer's disease in the brain. A ...
With the approval of anti-amyloid monoclonal antibodies to treat early-stage Alzheimer’s disease (AD), the need for accurate and early diagnosis is crucial. Blood-based biomarkers offer a promising ...
AI-driven blood test for Alzheimer’s launched in India, promising earlier diagnosis. Global trials for a finger-prick test could transform patient care.
A new blood test uses a portable diagnostic system to detect various different diseases in just 15 minutes. The test could change the way we diagnose a wide range of infectious diseases. Here's what ...
In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, accessible and inexpensive than other existing tests. When you purchase through ...
The U.S. Food and Drug Administration (FDA) recently cleared a blood test that detects signs of Alzheimer's disease in the brain, according to multiple studies. This is the first-ever blood test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results